Submit a Press Release | About | Blog | Help | Pricing & Sign Up
Over 30,000 companies use PR LEAP Learn More
Good Informatics Practices: From Bench - Through Regulator - To Bedside
(PRLEAP.COM) Phoenix, AZ – May 31, 2007 – Mission3, Inc., a leading provider of project, document, and electronic submission management software specifically serving the Life Sciences industry announced today that it continues its drive for Good Informatics Practices through its partnership with LSIT Global Institute with the publication of its article “The Flow of Data From Bench To Bedside: Finally Enabled by Electronic Submission”.
The adoption and implementation of successful IT strategies is required in order to create a more efficient and effective industry. Regardless of the size of the Life Science company, whether an establish company or a just established start up venture, the same pressing market issues apply from discovery through regulatory approval. By implementing GIP from the beginning through a cohesive IT strategy, early stage and middle market companies can derive the same benefit as large companies. In some case, this benefit has a better return on investment because good processes have been implemented from the start.
“The true power of IT systems is first realized as the data flows freely from one system to the other and, as Life Sciences companies automate more processes internally, integration will lead to increase efficiency and quality.” said Dirk Karsten Beth, President and Founder of Mission3. “The Mission3 suite of products helps Life Science companies accelerate product development from bench to bedside, by managing critical data from discovery through the full regulatory filing life cycle in one easy to implement package.”
The entire article is available for reading at: http://www.lsit.org/news/flow_of_data.php
“Mission3 continues to deliver on Good Informatics Practices. Together, Misison3 and LSIT are increasing the adoption of GIP in the Life Sciences industry, which will result in more efficient and effective companies that can deliver products to market quicker at reduced costs.” said Annette Asher, Executive Director of LSIT.
To learn more about LSIT and its mission, please visit: http://www.lsit.org
About Mission3, Inc.
Mission3 was founded to assist biotech, pharmaceutical, and medical device companies to bring needed therapies and devices to market quickly and efficiently. It’s state-of-the-art enterprise software suite allows companies to manage projects and documents; comply with regulatory requirements; and submit applications in an automated, electronic, and managed environment. Companies taking full advantage of Mission3’s industry leading enterprise suite can significantly reduce their time to market.
CONTACT INFORMATION:
Chris Joslin
Vice President of Operations
Mission3, Inc.
www.mission3.com
602-957-2150 ext. 508
cjoslin@mission3.com
Contact Information
About This News Release
If you have any questions regarding information in these press releases please contact the organization listed in the press release. Issuers of press releases and not PR Leap are solely responsible for the accuracy of the content.
